Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Y Xu

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Fa Yi Xue Za Zhi|February 7, 2021
[Research Progress on Estimation of Postmortem Submersion Interval]H Y Yuan, R Zhao, L N Gao, et al.
Cell Death & Disease|October 10, 2014
The bromodomain and extra-terminal inhibitor CPI203 enhances the antiproliferative effects of rapamycin on human neuroendocrine tumorsC Wong, S V Laddha, L Tang, et al.
Leukemia|December 27, 2016
Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199)V M Patel, K Balakrishnan, M Douglas, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Fa Yi Xue Za Zhi|February 7, 2021
[Research Progress on Estimation of Postmortem Submersion Interval]H Y Yuan, R Zhao, L N Gao, et al.
Cell Death & Disease|October 10, 2014
The bromodomain and extra-terminal inhibitor CPI203 enhances the antiproliferative effects of rapamycin on human neuroendocrine tumorsC Wong, S V Laddha, L Tang, et al.
Leukemia|December 27, 2016
Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199)V M Patel, K Balakrishnan, M Douglas, et al.
Pageof 2